Celularity Inc. Finite-Lived Intangible Assets, Net
Celularity Inc. (CELU) had Finite-Lived Intangible Assets, Net of $7.06 million as of 2025-12-31, per its 10-K filed 2026-04-30.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsNet · last filed 2026-04-30
- 2025-12-31: Finite-Lived Intangible Assets, Net $7.06M.
- 2025-09-30: Finite-Lived Intangible Assets, Net $7.43M.
- 2025-06-30: Finite-Lived Intangible Assets, Net $7.81M.
- 2025-03-31: Finite-Lived Intangible Assets, Net $8.18M.
| Period end | Finite-Lived Intangible Assets, Net |
|---|---|
| 2025-12-31 | $7.06M 10-K · filed 2026-04-30 |
| 2025-09-30 | $7.43M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $7.81M 10-Q · filed 2025-08-29 |
| 2025-03-31 | $8.18M 10-Q · filed 2025-08-29 |
| 2024-12-31 | $8.55M 10-K · filed 2026-04-30 |
| 2024-09-30 | $8.92M 10-Q · filed 2024-12-06 |
| 2024-06-30 | $9.30M 10-Q · filed 2024-11-07 |
| 2024-03-31 | $9.76M 10-Q · filed 2024-10-16 |
| 2023-12-31 | $10.30M 10-K · filed 2025-05-08 |
| 2023-09-30 | $10.85M 10-Q · filed 2024-01-03 |
| 2023-06-30 | $11.41M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $11.95M 10-Q · filed 2023-05-22 |
| 2022-12-31 | $12.49M 10-K · filed 2024-07-30 |
| 2022-09-30 | $13.05M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $13.60M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $14.15M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $14.69M 10-K · filed 2023-03-31 |
| 2021-09-30 | $15.24M 10-Q · filed 2021-11-12 |
| 2020-12-31 | $16.88M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |